Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cancer diagnostics company highlights method of detecting nuclear matrix protein complex
January 26th, 2006
Matritech (MZT) presented an improved method of detecting the NMP66 nuclear matrix protein complex in serum from women with breast cancer in a poster session during the 2005 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Matritech scientists have developed several methods to detect the NMP66 complex in serum including an immunoassay and a reverse transcriptase-polymerase chain reaction (RT-PCR) procedure. The scientists have continued to work on assay optimization including the development of methods to increase the sensitivity of the immunoassay. The results of one such method, which concentrates the NMP66 complex from a blood sample, were...
Source: Women's Health Weekly (2006-01-26)
|
